CoChat

Notch Activation as a Driver of Osteogenic Sarcoma

Open access
Tao, Jianning, Jiang, Ming-Ming, Jiang, Lichun, Salvo, Jason S., Zeng, Huan-Chang, Dawson, Brian, Bertin, Terry K., Rao, Pulivarthi H., Chen, Rui, Donehower, Lawrence A., Gannon, Francis, Lee, Brendan H. · 2014 · Cancer Cell
Cited by 134

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Summary Osteogenic sarcoma (OS) is a deadly skeletal malignancy whose cause is unknown. We report here a mouse model of OS based on conditional expression of the intracellular domain of Notch1 (NICD). Expression of the NICD in immature osteoblasts was sufficient to drive the formation of bone tumors, including OS, with complete penetrance. These tumors display features of human OS, namely histopathology, cytogenetic complexity, and metastatic potential. We show that Notch activation combined with loss of p53 synergistically accelerates OS development in mice although p53-driven OS is not Rbpj-dependent, which demonstrates a dual dominance of the Notch oncogene and p53 mutation in the development of OS. Using this model, we also reveal the osteoblasts as the potential sources of OS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2014.07.023

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Mutational heterogeneity in cancer and the search for new cancer-associated genes

    Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461 · cited 1×

    “Gainof-function mutations in NOTCH1 have been found in approximately 10% of cases of non-small-cell lung cancer (Lawrence et al., 2013; Westhoff et al., 2009), the leading cause of cancer-related deaths.”
    Background
  • Discovery and saturation analysis of cancer genes across 21 tumour types

    Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096 · cited 2×

    “Notch gain-of-function mutations have also been found in several types of solid tumors, including lung cancer (Lawrence et al., 2014; Westhoff et al., 2009).”
    Background
  • Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation

    Hilton, M. J., Tu, X., Wu, X., Bai, S., Zhao, H., Kobayashi, T., Kronenberg, H. M., Teitelbaum, S. L., Ross, F. P., Kopan, R., et al. (2008) · Nature Medicine · doi:10.1038/nm1716 · Cited by 604 · cited 6×

    “…through its targets, including Hes and Hey proteins, to positively regulate proproliferation factors such as cyclin D1 and negatively regulate prodifferentiation factors such as the Runx2 transcription factor (Engin et al., 2008; Hilton et al., 2008; Zamurovic et al., 2004; Zanotti et al., 2008).”
    BackgroundInfluential
  • Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.

    Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542 · cited 1×

    “In addition, very few mouse models possessing a high frequency of OS are currently available (Grigoriadis et al., 1993; Harvey et al., 1993; Molyneux et al., 2010).”
    BackgroundSelf-citation
  • Gene expression profiling of human sarcomas: insights into sarcoma biology.

    Baird, K., Davis, S., Antonescu, C. R., Harper, U. L., Walker, R. L., Chen, Y., Glatfelter, A. A., Duray, P. H., & Meltzer, P. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1699 · Cited by 353 · cited 3×

    “…the molecular similarity between human OS and the tumors induced by Notch activation in mice, we compared our RNA-seq expression profiles of NOS tumors with microarray-derived expression profiles from several published human sarcoma expression data sets (Baird et al., 2005; Henderson et al., 2005).”
    Method
  • Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression

    Paoloni, M., Davis, S., Lana, S., Withrow, S., Sangiorgi, L., Picci, P., Hewitt, S., Triche, T., Meltzer, P., & Khanna, C. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-625 · Cited by 291 · cited 2×

    “Human OS Gene Expression and GSEA Human data from Paoloni et al. (2009) were downloaded from the Gene Expression Omnibus gateway (http://www-ncbi-nlm-nih-gov.ezproxyhost. library.tmc.edu/geo/) using accession number GSE16091.”
    Method
  • Osteosarcoma.

    Gorlick, R., & Khanna, C. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.77 · Cited by 157

  • ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice

    Casimiro, M. C., Crosariol, M., Loro, E., Ertel, A., Yu, Z., Dampier, W., Saria, E. A., Papanikolaou, A., Stanek, T. J., Li, Z., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60256 · Cited by 115 · cited 2×

    “This is in agreement with recent reports showing that 394 Cancer Cell 26, 390–401, September 8, 2014 ª2014 Elsevier Inc. cyclin D1 and Runx2 are significantly involved in chromosomal instability and tumorigenesis in mice (Casimiro et al., 2012; Zaidi et al., 2007).”
    BackgroundResult

Cited by

See all 134

Metadata

Authors
Tao, J., Jiang, M.-M., Jiang, L., Salvo, J. S., Zeng, H.-C., Dawson, B., Bertin, T. K., Rao, P. H., Chen, R., Donehower, L. A., Gannon, F., & Lee, B. H.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2014-09
Volume
26
Issue
3
Pages
390-401
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2164693455
Cited by
134
References
8
FWCI
10.66
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.